Profile for Ukraine Patent: 103319
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for Ukraine Patent: 103319
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
⤷ Sign Up | Jul 20, 2030 | Novartis | TAFINLAR | dabrafenib mesylate |
⤷ Sign Up | Jul 20, 2030 | Novartis | TAFINLAR | dabrafenib mesylate |
⤷ Sign Up | Nov 4, 2029 | Novartis | TAFINLAR | dabrafenib mesylate |
>US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |